The level of insulin-like growth factor 1 (IGF-I) is influenced by many factors but, as detailed here, IGF-I measurements are useful to screen for growth hormone deficiencies in children and young ...

Tesamorelin, a synthetic growth hormone-releasing hormone (GHRH) analog, has garnered significant attention in scientific ...

First subcutaneous, once-monthly octreotide for treatment of acromegalyFor convenient self-administration with a pre-filled autoinjector penLUND, Sweden, ...

A recent study reveals a significant link between high BMI and increased breast cancer risk, particularly in postmenopausal women. The risk escalates further for those with cardiovascular disease, ...

Insulin and IGF-1 have specific and physiological vascular actions in humans and experimentally derived animals and cause an increase in SMBF and a decrease in vascular resistance.

Three people with type 1 diabetes who received Vertex Pharma’s islet cell therapy VX-880 were able to come off insulin within a year.

Investigators examined the comparative effectiveness of SGLT2 inhibitors and GLP-1 receptor agonists in a real-world setting.

Biomea Fusion Reports Preclinical Data for BMF-650, a Next-Generation Oral GLP-1 Receptor Agonist Candidate, Demonstrating Robust Weight Loss and Appetite Suppression in Obese Non-Human Primates ...

DiabetesMine explores how long a person with diabetes can live without insulin and how they can prolong life.

FDA rejects Novo Nordisk’s once-weekly basal insulin for people with diabetes, which would reduce the number of injections needed.

Diabetes occurs when your body is unable to use or make insulin properly, which affects your blood sugar (glucose) levels. Learn about its many possible causes.